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The role of microorganisms in the pathogenesis
of acne has been open to considerable debate
ever since Unna detected a short, pleomorphic
bacillus in histologic sections of comedones
(1). This organism, known as Gorynebacterium
acnes (Pro pioni bacterium acnes) , was first isolated
by Sabouraud from acne pustulcs, and it was
felt to play an important role in acne (2). How-
ever, when subsequently it was cultured from
normal skin (3), its significance in acne was
seriously questioned.
In the past decade, the role of bacteria in the
acne process has received considerable impetus
from the successful modification of the disease
by antibacterial agents (4—35). This represents
the only major addition to the modern therapy
of acne. While most of the reports on the anti-
biotic and sulfonamide therapy of acne have not
defined the bacteria involved, those studies, in
which specific organisms were identified (26—35),
have resulted in confusion rather than clarifica-
tion of the pathological significance of bacteria
in acne. The organisms isolated include a wide
variety of staphylococci (26—35), streptococci
(26, 28, 35), diphthcroids (26) and enteric
bacteria (35). A review of the reports reveals that
only rarely was mention made of testing the
coagulase activity of the isolated staphylococci
(33), and that, in most instances, the over-
whelmingly predominant organism recovered was
Staphylococcus albus. With rare exception (36)
there is no specific mention of the isolation of
Gorynebacterium acnes, a fact that is not surpris-
ing, because the organism is difficult to culture
on the usual laboratory media and requires
relative anaerobiosis for growth.
Certainly, part of the reason for this confusion
rests in the method of obtaining material for
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culture. In this regard, avoidance of surface
bacterial contamination is a prime consideration.
To this end, we feel that only the unopened lesions
are suitable for culture, and that these must be
sampled with a fine probe inserted into the depths
of the lesion. In a large series of cultures, we
have been unable to substantiate the culture
results of other investigators. We rarely have
recovered staphylococci, and these are almost
invariably coagulasc-ncgative. On the other
hand, we have isolated Gorynebacterium acnes
consistently and with consummate ease.
However, the successful recovery of organisms
does not necessarily signify pathogenicity, since
bacteria cultured from any lesion can also repre-
sent either the normal resident flora, or an altered
flora of non-resident pathogens which commonly
colonize areas of pre-existing inflammation, The
pitfall of assigning a pathogenic role to bacteria
merely on the basis of their recovery from skin
lesions has been stressed by Pillsbury and
Kligman (37). They have suggested that a more
definitive criterion for infection is the demonstra-
tion of organisms at the site of inflammation,
with an accompanying phagocytic response. In
viewing histopathologic sections of deep, in-
flammatory acne nodules, one of us (38) has
repeatedly observed bacteria which are morpho-
logically indistinguishable from Coryncbacteria.
These organisms are scattered throughout the
inflammatory infiltrate and arc often found
within polymorphonuclcar leukocytes.
Since we feel that Gorynebacterium acnes plays
a significant role in the pathogcnesis of acne,
the assessment of the ability of agents to control
this organism is of considerable importance.
Therefore, this study will detail the in vitro
antibiotic and sulfonamide sensitivity of Goryne-
bacterium acncs, with the use of the test tube
dilution technic. To our knowledge, only one
previous investigator has studied the antibiotic
sensitivity of this organism (39). Using a disc-
plate method, he found that Gorynebacterium
acnes was sensitive to penicillin, chlortctracycline,
chloramphenicol, oxytetracycline, picromycin
and streptomycin.
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THE CHARACTERISTICS OF CORYNEBACTERIUM
AGNES
This bacterium, which numerically is the
predominant organism of the normal resident
skin flora (40), was originally called the acne
bacillus (41). Subsequently, in view of its morpho-
logic resemblance to diphtheroids, it was assigned
the name, Corynebacterium ames (42). Because
of the nature of its catabolic processes, i.e.
the formation of propionic acid from glucose
under anaerobic conditions, Douglas suggested
that it be renamed Fropioni bacterium acnes (43).
Since we feel that the production of propionic
acid by this organism may be significant in the
formation of acne lesions, we prefer the name of
Propionibacterium acnes. However, controversy
still exists as to its exact taxonomic position, and
at present it remains classified as a Coryne-
bacterium (44).
This organism is a thin, irregularly gram-
positive pleomorphic rod, often approaching a
coccal shape, its length varying from 0.5—2.0 p.
Its growth is optimum at 37° C, and it has a
strong preference for anaerobic conditions. It is
catalase-positive, reduces nitrates and litmus
milk and liquefies gelatin. Fermentation, with
the production of propionic and acetic acids but
without the formation of visible gas, occurs with
glucose, mannose, fructose and galactoes.
Maltose, sucrose, lactose and lactic acid are not
fermented. On solid media, the colonies are
round, raised, smooth and glistening. Initially,
they are grayish-white, but in time turn salmon-
pink in color.
Growth as such, particularly on primary isola-
tion, is fastidious and slow on most media,
including those utilized by Douglas (43) and
Evans (40). Recently, a medium has been
described which supports luxuriant and rapid
growth of this organism (45). This medium was
primarily devised for the isolation of Actinomyces
species, and probably not all of the agents
incorporated in it are necessary for the growth of
Corynebacterium acnes. However, this problem
has not been investigated. Using this medium,
slightly modified and described below, we have
found that macroscopic growth occurs in 24—48
hours. Thus, the medium lends itself well to
standard antibiotic sensitivity technies.
Parts I and II are autoclaved separately, then
combined while still hot. The resulting medium,
being somewhat turbid, is filtered through three
filter papers (Whatman No. 1) and re-autoclaved.
The final solution is clear and suitable for tube
sensitivity testing.
Anaerobic conditions are achieved by the use
of a pyrogallol-sodium carbonate seal. The sterile
cotton plug of the test tube is saturated with
five drops each of pyrogallic acid solution (100
gm/iSO ml. H2O) and sodium carbonate solution
(10 gm./100 ml. H2O). The tube is then immedi-
ately sealed with a rubber stopper.
METHODS
A serial test tube dilution technic has been
used with final antibiotic concentrations of 100,
50, 25, 12.5, 6.25, 3.12, 1.56, 0.8, 0.4 and 0.2 micro-
grams of active agent per 1.0 ml. of liquid culture
medium. The active agents, dissolved in sterile
distilled water, were added to the first tube of each
series and then diluted by a standard twofold
serial dilution method. The compounds tested
have included: penicillin, erythromyein, de-
methylchlortetracycline, tetracycline, ehlortetra-
cycline, chloramphenicol, novobiocin, oxytetra-
cycline, streptomycin, neomyein, sulfisoxazole,
sulfamethoxypyridazine and sulfadimethoxine . *
Organisms were grown in liquid media for 48
hours at 37° C., and then diluted with sufficient
medium to give a uniform density of 250—300 mu
in a Klett-Summerson photoelectric colorimeter
with a blue filter (No. 42). The inoculum, which
was added to each tube, consisted of 0.05 ml. of
this bacterial suspension. After incubation for 72
hours, the end-point was determined as the tube
with the smallest concentration of antibacterial
agent not showing cloudy growth.
The data to be presented are based on the
testing of twelve strains of Corynebacterium ccnes
against the antibiotics and sulfooamides listed
above. In several instances, single strains were
repeatedly tested. Six strains were obtained from
* We are grateful to the following companies for
supplying material used in this study:
1. Lederle Laboratories, Division of American
Cyanamid Co., for chlortetracycline (Aureomy-
cm®), demethylchlortetracycline (Declomycinu)
and sulfamethoxypyridazine (Kynex®).2. Parke, Davis & Co., for ehloramphenicol
(Chloromycetin®).3. Pfizer Laboratories, Division, Chas. Pfizer
& Co. Inc., for penicillin and oxytetracycline
(Terramyein®).
4. Roche Laboratories, Division of Hoffman-
La Roche Inc., for sulfisoxazole (Gantrismn®) and
sulfadimethoxine (Madrib on®).5. The Upjohn Company, for tetracycline
(Panmycin'5), novobiocin (Albamycmn®), erythro-
mycin and neomycin.
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Description of Culture Medium
Basal solutions or chemicals Amounts Used
Part I.
A. Actinonxyees salts. 250 ml.
K112P04
(Nil4) 2S04
Mg504 7il20
CaC12
B. Minor elements.
FeS04711i0 2.0 gm.
MnS042H20 0.075 gm.500 ml. H20
NaMo042il20 0.075 gmj
Add 1.0 ml. cone. ilCl to 100 ml. distilled water; then add minor elements
separately, and dilute to 500 ml.
C. Purines and pyrimidines.
Adenine sulfate 0.2 gm .1
Guanine ilCl2il20 0.2 gmj
Uracil 0.2 gm.}100 ml. 1120
Xanthine 0.2 gm.
Thymine 0.2 gm.
D. [(lines vitamin solution
Thiamine HCI 0.02 gm.
Pyridoxine HC1 0.01 gm.
Pyridoxamioe 2HCI 0.005 gm.
Pyridoxal HC1 0.005 gm.
Calcium pantothenate 0.02 gm. m. 2Riboflavin 0.02 gm.
Nicotinamide 0.01 gm.
p-Aminobenzoic acid 0.001 gm.
Biotin 0.0005 gm.
Folic acid 0.0005 gm.
E. Casitone
F. Cysteine HC1
G. Yeast extract
Part I is adjusted to pH 6.5 with 20% potassium hydroxide and diluted to 500
ml.
Part II.
A. Distilled water
B. Glucose
C. Starch (purified)
D. Sodium oleate
E. Agar (regular)—(omit except when making solid medium)
methylehiortetracycline were the most effective
antibiotics inhibiting growth of Corynebacteriuni.
acnes. The remainder of the broad-spectrum
antibiotics dcmonstratcd moderate suppression
of growth, with the exception of neomycin and
streptomycin which showed little or no anti-
bacterial action. The sulfonamides tested were
completely ineffectual, even when concentrations
as high as 500 micrograms/ml. were employed.
In Table 1, the average maximum serum
concentration of antibiotic or sulfonamide
achieved in man with the indicated dose is
compared with the average minimum concentra-
60.0 gm.
11000 ml. 11204.0 gm.0.8gm.
0.08 gm.J
10 ml.
10 ml.
10 ml.
4.0 gm.
1.0 gui.
1.0 gm.
500 ml.
5.0 gui.
1.0 gm.
0.001 gm.
7.0 gm.
the American Type Culture Collection;t the six
others were isolated by us from patients with
acne. Other strains, not included in this report,
have been similarly tested against some of the
antibiotics, and have demonstrated a comparable
sensitivity response.
EE5ULT5
The results appear in Fig. 1. On a comparative
weight basis, penicillin, erythromycin and de-
One of the strains from the American Type
Culture Collection was also obtained from Dr.
Leo Pine, Department of Bacteriology, Duke
University School of Medicine. Its sensitivity was
the same from both sources.
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FIG. 1. Minimum antibiotic and sulfonamide concentrations inhibiting growth of Corynebacterium
acnes. (End-point: that tube with the smallest eoocentration of antibacterial not showing cloudy
growth). Each vertical line represents an individual strain tested to the specific antibacterial agent.
TABLE 1
Correlation of in vivo serum concentrations of antibiotics and in vitro minimum inhibitory antibiotic
concentrations
.Antibiotic Dose
Average Maximum
Serum Concentration(g/m!)
Average Minimum
Inhibitory Coorentra-
tine (g/ml)
Penicillin (potassium G) 400,000 uu.
(0.25 gm.)
0.9 (46)* <0.2
Erythromycin 0.25 gm. 2.3 (47) <0.2
Demcthylchlortetracycline 0.25 gm. 4.0 (48) 0.47
Tetracycline 0.25 gm. 2.0 (49) 1.31
Chlortetracyclinc 0.25 gm. 2.0 (50) 1.37
Chloramphcnicol 0.50 gm. 5.0 (51) 1.57
Novobiocin 0.25 gm. 10.5 (52) 1.70
Oxytctracyclinc 0.25 gm. 2.0 (53) 1.89
Streptomycin 0.5 gm. 15.0 (54) >100
Sulfisoxazole 4.0 gm. 196.0 (55) >500
Sulfamethoxypyridazine 1.0 gm. 121.5 (56) >500
Sulfadimcthoxine 1.0 gm. 54.9 (57) >500
* Reference sources in parentheses.
tion of the agent which will inhibit growth of
Corynebacterium acnes in vitro, as determined by
us. The minimum inhibitory concentrations are
lower than the serum concentrations obtained
with the dosages shown, with the exception of
streptomyein and the sulfonamides. Here, the
minimum inhibitory concentrations far exceed
serum levels. However, it should be pointed out
that there may be no direct correlation between
the in vivo serum concentrations and the in
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vitro activity against Corynebacterium aenes. In
addition, the serum concentrations shown repre-
sent average values and may vary considerably,
depending upon individual differences in absorp-
tion, degradation and excretion of these com-
pounds.
DISCUSSION
While the results presented are quite uniform
and show a decided in vitro sensitivity of this
organism to penicillin and most of the broad-
spectrum antibiotics, one phenomenon compli-
cated the readings and required considerable
investigation before a definitive end-point could
be established. This was the appearance of a
white coagulum in the tubes containing broad-
spectrum antibiotics (erythromycin, demethyl-
chlortetracycline, tetracycline, chlortetracycline,
chloramphenicol, novobiocin and oxytetracy-
dine). This coagulum, which was not observed
in control tubes containing the antibiotic alone
with media or in those containing only the
bacteria and media, had the following charac-
teristics:
(1) it appeared in 6—8 hours, long before
macroscopic growth was evident, and remained
unchanged after two weeks' observation.
(2) it appeared at all dilutions of antibiotic,
but more prominently so in the higher concen-
trations.
(3) its formation was not prevented by
constant shaking of the tubes during the 3-day
incubation period.
(4) it could be disrupted by marked agita-
tion, but never dissolved into a uniform suspen-
sion.
(5) exclusion of casein from the medium did
not prevent its formation.
(6) on microscopic examination, it contained
normal-appearing Corynebacterin, and when it
was washed in saline and subsequently planted
onto solid media, growth of Corynebacteria
ensued in 24—48 hours, as usual. These were
normal in appearance, grossly and microscopi-
cally, and were identified as Corynebacterium
aenes by fermentation tests.
At first glance, these findings tend to invalidate
the conclusions, but, in our opinion, other studies
to be described below indicate that this was not
actual growth of the organism, but rather some
sort of physical reaction between the inoculated
organisms and the culture medium. First of all,
as already mentioned, the curd appeared in 6—8
hours, at a time when there is no turbidimetric
evidence of growth in control culture tubes.
Second, a distinct end-point was observed
between tubes with coagulum alone and those
with coagulum plus cloudiness. Third, as an
acid producer, this organism normally induces
pH changes in its medium. The pH of the medium
employed was 6.5, which was unaltered by the
presence of the various antibiotics, before and
after incubation. Where coagulum alone was
observed, the pH remained unchanged (6.5); but
where cloudiness was noted, the pH was meas-
urably lowered (6.2—5.7).
Of greatest significance, however, is the finding
that when paired sensitivity studies were carried
out, with the antibiotics being incorporated both
in liquid and solid media, visible growth on solid
media occurred only in those concentrations in
which cloudy growth appeared in liquid media.
With the higher concentrations of the antibiotics,
such as those in which the curd alone was
observed in the liquid media, there was no growth
on solid media. Obviously, then, the routine use
of solid media would be preferable, but the
technical difficulties of incorporating serial
dilutions of antibiotics render the use of solid
media impractical. Nevertheless, the absolute
correlation obtained validates the results in the
liquid media.
A word is necessary concerning the correlation
of the sensitivity results with the clinical experi-
ence in treating acne with antibiotics and
sulfonamides. These compounds, of course, are
ineffective in the treatment of non-infected
lesions, such as comedones; their value lies in
the control of deep, nodular infected lesions. Our
major experience has been with the use of the
tetracycline group of compounds. While recog-
nizing that the natural fluctuations in the course
of acne are so great as to make clinical evaluation
extremely difficult, we arc in general agreement
with most of the published work that these are
the most useful antibacterial agents in acne.
We have also found penicillin to be effective in
acne, although less so than the tetracyclines.
The reason for this discrepancy between the
in vitro sensitivity results and the clinical response
is unclear. However, it has been our experience
that sulfonamides are not particularly useful in
acne, and the in vitro results obtained with these
substances support this observation.
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SUMMARY
Corynebacterium acnes (Propionibacterium
acnes) was tested for its in vitro antibiotic and
sulfonamide sensitivity with the nse of the
standard test tube dilution technic.
By this method, the organism is sensitive to
penicillin, erythromycin, demethylchlortetra-
cyclinc, tetracycline, chlortctracycline, chlor-
amphenicol, novobiocin and oxytetracycline;
and insensitive to streptomycin, neomycin,
suffisoxazole, sulfamcthoxypyridazine and sulfa-
dimethoxine.
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